CONOR MEDSYSTEMS IMPLANTS THE FIRST PATIENT WITH A DUAL-DRUG HEART DEVICE

Conor Medsystems said May 18 it has implanted a stent that can deliver two drugs to help keep an artery clear. The move is part of the race to tap the more than $5.5-billion drug-delivering stent industry, where innovation will be the force to eventually take market share away from the relative duopoly held by Johnson & Johnson and Boston Scientific.

Red Herring (http://www.redherring.com/Article.aspx?a=16922&hed=Stent%2BCarries%2B2%2BDrugs%2Bat%2BOnce§or=Industries&subsector=Biosciences)